Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 3Congenital Abnormalities 3Urinary Bladder Neoplasms 1Small Cell Lung Carcinoma 1Myelodysplastic Syndromes 1Lymphoma 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Carcinoma, Non-Small-Cell Lung 1Burkitt Lymphoma 1Blast Crisis 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Cyclophosphamide 59Peripheral Blood Stem Cell Transplantation 51fludarabine phosphate 47Busulfan 39Tacrolimus 38Methotrexate 35Mycophenolic Acid 31Filgrastim 30Cyclosporine 30Cytarabine 29Whole-Body Irradiation 28Antilymphocyte Serum 28Radiotherapy 22Methylprednisolone 18Etoposide 18Melphalan 17Cord Blood Stem Cell Transplantation 17Imatinib Mesylate 13Flow Cytometry 13Thiotepa 11Therapeutics 11merphos 10fludarabine 10Granulocyte Colony-Stimulating Factor 10Sirolimus 8Rituximab 8Psychiatric Rehabilitation 8Prednisone 8sargramostim 7Dexamethasone 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Blast Crisis × Podophyllotoxin × Clear all
NCT00540995 2023-11-30

Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer

City of Hope Medical Center

Phase 1/2 Terminated
25 enrolled 9 charts
Classical hematologyOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡